Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

J&J Consumer Recaptures Growth, Plans To Restore Most OTCs By Mid-2012

This article was originally published in The Tan Sheet

Executive Summary

Johnson & Johnson reported July 19 the first period of positive growth for its consumer unit in more than a year.

You may also be interested in...



J&J Settles Class Action For “Misleading” Neutrogena Naturals Claims

The case hinges on claims used to promote Neutrogena Naturals cleansers and moisturizers – specifically, that they are “natural products that contain no petrochemicals,” according to court documents. The consumer plaintiffs say they paid a premium over “comparable products” on the basis of those claims.

J&J Brand Revival Plan Relies On Marketing, Delivery Innovation

Johnson & Johnson expects innovation and marketing to restore consumer confidence in its OTC brands and drive a market-share rebound even as its U.S. sales continue to fall, dropping nearly 25% in its latest quarter.

J&J Brand Revival Plan Relies On Marketing, Delivery Innovation

Johnson & Johnson expects innovation and marketing to restore consumer confidence in its OTC brands and drive a market-share rebound even as its U.S. sales continue to fall, dropping nearly 25% in its latest quarter.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS105197

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel